Himalaya Therapeutics Announces Submission in Mainland China of IND Applications for its CAB-AXL-ADC to treat sarcomas and NSCLC, its CAB-ROR2-ADC to treat melanoma and NSCLC

Himalaya Therapeutics Announces Submission In Mainland China Of Ind Applications For Its Cab Axl Adc To Treat Sarcomas And Nsclc, Its Cab Ror2 Adc To Treat Melanoma And Nsclc

Facebook Comments

Leave a Reply

CommentLuv badge